232 related articles for article (PubMed ID: 29022296)
1. Efficacy and Safety of Intracameral Bevacizumab for Treatment of Neovascular Glaucoma.
Ha JY; Lee TH; Sung MS; Park SW
Korean J Ophthalmol; 2017 Dec; 31(6):538-547. PubMed ID: 29022296
[TBL] [Abstract][Full Text] [Related]
2. In vivo corneal endothelial safety of intracameral bevacizumab and effect in neovascular glaucoma combined with Ahmed valve implantation.
Shin JP; Lee JW; Sohn BJ; Kim HK; Kim SY
J Glaucoma; 2009; 18(8):589-94. PubMed ID: 19826387
[TBL] [Abstract][Full Text] [Related]
3. Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients.
Duch S; Buchacra O; Milla E; Andreu D; Tellez J
J Glaucoma; 2009 Feb; 18(2):140-3. PubMed ID: 19225351
[TBL] [Abstract][Full Text] [Related]
4. The effect of different doses of intracameral bevacizumab on surgical outcomes of trabeculectomy for neovascular glaucoma.
Gupta V; Jha R; Rao A; Kong G; Sihota R
Eur J Ophthalmol; 2009; 19(3):435-41. PubMed ID: 19396791
[TBL] [Abstract][Full Text] [Related]
5. Intracameral injection of bevacizumab for the treatment of neovascular glaucoma.
Wolf A; von Jagow B; Ulbig M; Haritoglou C
Ophthalmologica; 2011; 226(2):51-6. PubMed ID: 21546781
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study.
Inatani M; Higashide T; Matsushita K; Nagasato D; Takagi H; Ueki M; Takai Y; Miyazaki K; Iwamoto Y; Kobayashi M; Leal S
Adv Ther; 2021 Feb; 38(2):1106-1115. PubMed ID: 33330959
[TBL] [Abstract][Full Text] [Related]
8. Ahmed glaucoma valve implantation versus suprachoroidal silicone tube implantation following the injection of bevacizumab into the anterior chamber in patients with neovascular glaucoma.
Simsek T; Bilgeç MD
Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):799-804. PubMed ID: 30610423
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
Moraczewski AL; Lee RK; Palmberg PF; Rosenfeld PJ; Feuer WJ
Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917
[TBL] [Abstract][Full Text] [Related]
10. Concentration of vascular endothelial growth factor after intracameral bevacizumab injection in eyes with neovascular glaucoma.
Lim TH; Bae SH; Cho YJ; Lee JH; Kim HK; Sohn YH
Korean J Ophthalmol; 2009 Sep; 23(3):188-92. PubMed ID: 19794946
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy.
Mahdjoubi A; Najean M; Lemaitre S; Dureau S; Dendale R; Levy C; Rouic LL; Desjardins L; Cassoux N
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):411-420. PubMed ID: 29116399
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Ex-PRESS mini glaucoma shunt implantation with preoperative intracameral bevacizumab injection in refractory neovascular glaucoma.
Guven Yilmaz S; Yildirim S; Degirmenci C; Ates H
Eur J Ophthalmol; 2016 Nov; 26(6):575-580. PubMed ID: 26951529
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial.
Yazdani S; Hendi K; Pakravan M; Mahdavi M; Yaseri M
J Glaucoma; 2009; 18(8):632-7. PubMed ID: 19826393
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy.
Eid TM; Radwan A; el-Manawy W; el-Hawary I
Can J Ophthalmol; 2009 Aug; 44(4):451-6. PubMed ID: 19606170
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing Ahmed glaucoma valve implantation: 2-year follow-up.
Arcieri ES; Paula JS; Jorge R; Barella KA; Arcieri RS; Secches DJ; Costa VP
Acta Ophthalmol; 2015 Feb; 93(1):e1-6. PubMed ID: 24989855
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Outcome of Intravitreal Bevacizumab Followed by Ahmed Valve Implantation in the Management of Neovascular Glaucoma.
Tailor R; Kinsella MT; Clarke JC
Semin Ophthalmol; 2018; 33(5):606-612. PubMed ID: 28992424
[TBL] [Abstract][Full Text] [Related]
17. Clinical and electrophysiologic outcome in patients with neovascular glaucoma treated with and without bevacizumab.
Wittström E; Holmberg H; Hvarfner C; Andréasson S
Eur J Ophthalmol; 2012; 22(4):563-74. PubMed ID: 22139613
[TBL] [Abstract][Full Text] [Related]
18. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
Alkawas AA; Shahien EA; Hussein AM
J Glaucoma; 2010 Dec; 19(9):622-6. PubMed ID: 20179624
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive intravitreal bevacizumab-combined trabeculectomy versus trabeculectomy alone in the treatment of neovascular glaucoma.
Chen CH; Lai IC; Wu PC; Chen YJ; Chen YH; Lee JJ; Liu YC; Kuo HK
J Ocul Pharmacol Ther; 2010 Feb; 26(1):111-8. PubMed ID: 20148654
[TBL] [Abstract][Full Text] [Related]
20. Intracameral Avastin dramatically resolves iris neovascularization and reverses neovascular glaucoma.
Chalam KV; Gupta SK; Grover S; Brar VS; Agarwal S
Eur J Ophthalmol; 2008; 18(2):255-62. PubMed ID: 18320519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
